Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Hans Lentzen
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Concepts & Ideas
Procedures
Sign-in to see full Profile
Network (preview)
7
Mengs, U
6
Schwarz, T
5
Zinke, H
5
Möckel, Babette
5
Eck, Jürgen
5
Hajto, T
5
Langer, Martin
5
Hostanska, Katarina
3
Witthohn, Klaus
3
Saller, Reinhard
3
Weber, K
2
Stolte, Hilmar
2
Tonevitsky, Alexander
2
Pfueller, U
2
Palmer, Rex
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Hans Lentzen (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Bergmann Lothar; Aamdal Steiner; Marreaud Sandrine; Lacombe Denis; Herold Manfred; Yamaguchi Takuhiro; Wilhelm-Ogunbiyi Karin; Lentzen Hans; Zwierzina Heinz;
Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: a study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001).
European journal of cancer (Oxford, England : 1990) 2008;44(12):1657-62.
-
2004: Müthing Johannes; Meisen Iris; Bulau Patrick; Langer Martin; Witthohn Klaus; Lentzen Hans; Neumann Ulrich; Peter-Katalinic Jasna
Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residues.
Biochemistry 2004;43(11):2996-3007.
-
2001: Schaffrath B; Mengs U; Schwarz T; Hilgers R D; Beuth J; Möckel B; Lentzen H; Gerstmayer B
Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice.
Anticancer research 2001;21(6A):3981-7.
-
1999: Langer M; Möckel B; Eck J; Zinke H; Lentzen H
Site-specific mutagenesis of mistletoe lectin: the role of RIP activity in apoptosis.
Biochemical and biophysical research communications 1999;264(3):944-8.
-
1999: Eck J; Langer M; Möckel B; Witthohn K; Zinke H; Lentzen H
Characterization of recombinant and plant-derived mistletoe lectin and their B-chains.
European journal of biochemistry / FEBS 1999;265(2):788-97.
-
1999: Eck J; Langer M; Möckel B; Baur A; Rothe M; Zinke H; Lentzen H
Cloning of the mistletoe lectin gene and characterization of the recombinant A-chain.
European journal of biochemistry / FEBS 1999;264(3):775-84.
-
1999: Hostanska K; Hajto T; Fischer J; Mengs U; Weber K; Lentzen H; Saller R
Selective modulation of phosphatidylserine exposure on subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro.
Cancer detection and prevention 1999;23(6):511-23.
-
1999: Mengs U; Witthohn K; Schwarz T; Lentzen H
[Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties]
Wiener medizinische Wochenschrift (1946) 1999;149(8-10):262-4.
-
1998: Sweeney E C; Tonevitsky A G; Palmer R A; Niwa H; Pfueller U; Eck J; Lentzen H; Agapov I I; Kirpichnikov M P
Mistletoe lectin I forms a double trefoil structure.
FEBS letters 1998;431(3):367-70.
-
1998: Shumakov V I; Maisjuk I G; Agapov I I; Shamshiev A T; Muromtceva I B; Maluchenko N V; Pfueller U; Palmer R A; Lentzen H; Tonevitsky A G
In vitro efficacy of conjugates of anti-CD45 monoclonal antibodies with plant toxin A-chains.
Transplantation proceedings 1998;30(4):971-3.
-
1998: Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen T R; Weyhenmeyer R; Lentzen H
Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
Arzneimittel-Forschung 1998;48(5):497-502.
-
1998: Hajto T; Hostanska K; Weber K; Zinke H; Fischer J; Mengs U; Lentzen H; Saller R
Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo.
Natural immunity 1998;16(1):34-46.
-
1997: Möckel B; Schwarz T; Zinke H; Eck J; Langer M; Lentzen H
Effects of mistletoe lectin I on human blood cell lines and peripheral blood cells. Cytotoxicity, apoptosis and induction of cytokines.
Arzneimittel-Forschung 1997;47(10):1145-51.
-
1996: Weber K; Mengs U; Schwarz T; Becker H; Lentzen H
Stimulation of neutropoiesis by a special standardized mistletoe preparation after cyclophosphamide chemotherapy in mice.
Arzneimittel-Forschung 1996;46(12):1174-8.
-
1996: Bokemeyer C; Fels L M; Dunn T; Voigt W; Gaedeke J; Schmoll H J; Stolte H; Lentzen H
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.
British journal of cancer 1996;74(12):2036-41.
-
1996: Joller P W; Menrad J M; Schwarz T; Pfüller U; Parnham M J; Weyhenmeyer R; Lentzen H
Stimulation of cytokine production via a special standardized mistletoe preparation in an in vitro human skin bioassay.
Arzneimittel-Forschung 1996;46(6):649-53.
-
1996: Gaedeke J; Fels L M; Bokemeyer C; Mengs U; Stolte H; Lentzen H
Cisplatin nephrotoxicity and protection by silibinin.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(1):55-62.
-
1996: Hostanska K; Hajto T; Weber K; Fischer J; Lentzen H; Sütterlin B; Saller R
A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes.
Natural immunity 1996;15(6):295-311.
-
1995: Hostanska K; Hajto T; Spagnoli G C; Fischer J; Lentzen H; Herrmann R
A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells.
Natural immunity 1995;14(5-6):295-304.
Sign-in to see more
